RADNOR, Pa., Jan. 08, 2022 (GLOBE NEWSWIRE) — The law firm of
Kessler Topaz Meltzer & Check, LLP
informs investors that a securities class action lawsuit has been filed against in the United States District Court for the Eastern District of New York against DocuSign, Inc. (“DocuSign”) (
NASDAQ: DOCU
). The action charges DocuSign with violations of the federal securities laws, including omissions and fraudulent misrepresentations relating to the company’s business, operations, and prospects. As a result of DocuSign’s materially misleading statements to the public, DocuSign investors have suffered significant losses.
CANNOT VIEW THIS VIDEO? PLEASE
CLICK HERE
CLICK HERE
TO
SUBMIT
YOUR DOCUSIGN
LOSSES
LEAD PLAINTIFF DEADLINE:
February 22, 2022
CLASS PERIOD: March 27, 2020 through December 2, 2021
CONTACT AN ATTORNEY TO DISCUSS YOUR RIGHTS
:
James Maro, Esq. (484) 270-1453 or Toll Free (844) 887-9500 or Email at
[email protected]
DOCUSIGN’S
ALLEGED MISCONDUCT
DocuSign provides cloud based software in the United States and internationally. Specifically, DocuSign offers e-signature solutions that enables businesses to digitally prepare, sign, act on, and manage agreements.
Beginning on March 27, 2020 and throughout the Class Period, DocuSign touted its growth and continued strong demand. As recently as September 2, 2021 earnings call, DocuSign touted its billings and revenue growth, including, among other things, assuring investors that the company continued to see strong early renewals and expansions of existing customers that DocuSign had visibility into and tracked, and that DocuSign did not see significant slowdown in its business.
Then, on December 2, 2021, after the market closed, DocuSign announced that it sustained a significant deceleration in billings growth and disappointing year-end projections for billings and revenue. According to DocuSign, “After six quarters of accelerated growth, [DocuSign] saw customers return to more normalized buying patterns, resulting in 28% year-over-year billings growth.” Following this news, DocuSign’s stock price fell $98.73 per share, or 42%, to close at $135.09 per share on December 3, 2021.
WHAT CAN I DO?
DocuSign investors may,
no later than February 22, 2022
, seek to be appointed as a lead plaintiff representative of the class through
Kessler Topaz Meltzer & Check, LLP
or other counsel, or may choose to do nothing and remain an absent class member.
Kessler Topaz Meltzer & Check, LLP
encourages DocuSign investors who have suffered significant losses to contact the firm directly to acquire more information.
CLICK HERE
TO SIGN UP FOR THE CASE
WHO CAN BE A LEAD PLAINTIFF?
A lead plaintiff is a representative party who acts on behalf of all class members in directing the litigation. The lead plaintiff is usually the investor or small group of investors who have the largest financial interest and who are also adequate and typical of the proposed class of investors. The lead plaintiff selects counsel to represent the lead plaintiff and the class and these attorneys, if approved by the court, are lead or class counsel. Your ability to share in any recovery is not affected by the decision of whether or not to serve as a lead plaintiff.
ABOUT KESSLER TOPAZ MELTZER & CHECK, LLP
Kessler Topaz Meltzer & Check, LLP
prosecutes class actions in state and federal courts throughout the country and around the world. The firm has developed a global reputation for excellence and has recovered billions of dollars for victims of fraud and other corporate misconduct. All of our work is driven by a common goal: to protect investors, consumers, employees and others from fraud, abuse, misconduct and negligence by businesses and fiduciaries. At the end of the day, we have succeeded if the bad guys pay up, and if you recover your assets. The complaint in this action was not filed by Kessler Topaz Meltzer & Check, LLP. For more information about
Kessler Topaz Meltzer & Check, LLP
please visit
www.ktmc.com
.
CONTACT:
Kessler Topaz Meltzer & Check, LLP
James Maro, Jr., Esq.
280 King of Prussia Road
Radnor, PA 19087
(844) 887-9500 (toll free)
[email protected]
A video accompanying this announcement is available at:
https://www.globenewswire.com/NewsRoom/AttachmentNg/301be8b1-e1aa-427d-9a93-aff7a15112bf